Broncus Holding Corporation (02216.HK)株価、チャート、ニュース、およびAI分析

Q: Broncus Holding Corporation のCEOは誰ですか？

Mr. Hong Xu は Broncus Holding Corporation の Executive Chairman of the Board で、2021 から在籍しています。

Q: BRONCUS-B の株価パフォーマンスは？

BRONCUS-B の現在の価格は $2.37 で、最終取引日から 2.06% 減少 変動しました。

Q: Broncus Holding Corporation の主な事業テーマや業界は？

Broncus Holding Corporation は Health Care 業界、セクターは Health Care に属しています。

Q: Broncus Holding Corporation の時価総額はいくらですか？

Broncus Holding Corporation の現在の時価総額は $1.2B です。

ホーム

株式

02216.HK

BRONCUS-B (02216.HK)

Broncus Holding Corporation

HK$2.37

-2.06%

$-0.04

休場: Jan 19, 16:00:00 HKT

主要データ

前終値

$2.45

始値

$2.42

当日レンジ

$2.37 - $2.43

52週レンジ

$0.58 - $3.72

取引高

770.5K

平均取引高

855.2K

1株当たり利益(TTM)

-0.23

配当利回り

時価総額

$1.2B

BRONCUS-Bとは何ですか？

Broncus Holding Corp. engages in the research and development, and manufacturing, and commercialization of medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 193 full-time employees. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

特徴

取引戦略